| scholarly article | Q13442814 |
| P50 | author | Guillermo Garcia-Manero | Q66385413 |
| P2093 | author name string | Alfonso Quintás-Cardama | |
| Hui Yang | |||
| Jerald Radich | |||
| Koyu Hoshino | |||
| Hongyui Dai | |||
| P2860 | cites work | JunB differs from c-Jun in its DNA-binding and dimerization domains, and represses c-Jun by formation of inactive heterodimers | Q38321318 |
| JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression | Q39922891 | ||
| DNA methylation changes in hematologic malignancies: biologic and clinical implications | Q41455032 | ||
| Quantitative measure of c-abl and p15 methylation in chronic myelogenous leukemia: biological implications | Q41731985 | ||
| Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. | Q41740883 | ||
| Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome | Q41743756 | ||
| Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation | Q42736547 | ||
| Promoter-specific trans-activation and inhibition mediated by JunB. | Q42807266 | ||
| Opposite functions of jun-B and c-jun in growth regulation and neuronal differentiation | Q42813493 | ||
| Gene expression profiling in chronic myeloid leukemia patients treated with hydroxyurea | Q44086022 | ||
| JunB gene expression is inactivated by methylation in chronic myeloid leukemia | Q44265483 | ||
| Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer | Q44756573 | ||
| Acute leukaemia in bcr/abl transgenic mice | Q46334847 | ||
| DNA methylation and environmental exposures in human hepatocellular carcinoma | Q46624423 | ||
| Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun | Q46914063 | ||
| JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells. | Q52086238 | ||
| ABL1 methylation is a distinct molecular event associated with clonal evolution of chronic myeloid leukemia. | Q53781453 | ||
| The fundamental role of epigenetic events in cancer | Q56421597 | ||
| Chronic Myeloid Leukemia with Increased Granulocyte Progenitors in Mice Lacking JunB Expression in the Myeloid Lineage | Q58326895 | ||
| Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix | Q74186049 | ||
| Methylation of the ABL1 promoter in chronic myelogenous leukemia: lack of prognostic significance | Q74588016 | ||
| jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun | Q24302170 | ||
| Expression of c-jun, jun B and jun D proto-oncogenes in human peripheral-blood granulocytes | Q24529543 | ||
| Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation | Q24533533 | ||
| Control of cell cycle progression by c-Jun is p53 dependent | Q24607483 | ||
| Worms gang up on bacteria | Q27860588 | ||
| Gene expression profiling predicts clinical outcome of breast cancer | Q27860732 | ||
| Cadherin-13, a mediator of calcium-dependent cell-cell adhesion, is silenced by methylation in chronic myeloid leukemia and correlates with pretreatment risk profile and cytogenetic response to interferon alfa | Q28191349 | ||
| JunB is essential for mammalian placentation | Q28589940 | ||
| The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation | Q29400446 | ||
| Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia | Q29614280 | ||
| Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer | Q29615066 | ||
| AP-1 as a regulator of cell life and death | Q29616558 | ||
| Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer | Q29617394 | ||
| DNA methylation, methyltransferases, and cancer | Q30993657 | ||
| Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemia | Q33186068 | ||
| DNA hypermethylation in tumorigenesis: epigenetics joins genetics | Q33870798 | ||
| Gene expression changes associated with progression and response in chronic myeloid leukemia | Q34479561 | ||
| COBRA: a sensitive and quantitative DNA methylation assay | Q34630070 | ||
| Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. | Q34668770 | ||
| DNA methylation changes in leukaemia | Q34792998 | ||
| In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells | Q35066876 | ||
| Epigenetic targets in hematopoietic malignancies | Q35551110 | ||
| Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma | Q35807817 | ||
| Interleukin 6 induces DNA binding activity of AP1 in M1 myeloblastic cells but not in a growth resistant cell derivative | Q38317093 | ||
| P433 | issue | 10 | |
| P921 | main subject | leukemia | Q29496 |
| P304 | page(s) | 1361-1366 | |
| P577 | publication date | 2009-05-05 | |
| P1433 | published in | Leukemia Research | Q15716445 |
| P1476 | title | Downregulation of JUNB mRNA expression in advanced phase chronic myelogenous leukemia | |
| P478 | volume | 33 |
| Q54442290 | Co-expression of HoxA9 and bcr-abl genes in chronic myeloid leukemia. |
| Q47235766 | How is the relationship between TWIST-1 and BCR-ABL1 gene expressions in Chronic Myeloid Leukemia Patients? |
| Q53314331 | Inhibition of Ras-mediated signaling pathways in CML stem cells. |
| Q37853939 | Mechanisms controlling hematopoietic stem cell functions during normal hematopoiesis and hematological malignancies |
Search more.